Elevated serum levels of soluble CD154 in children with juvenile idiopathic arthritis

Pediatric Rheumatology

Volumn 6, Issue , 2008, Pages

  Prahalad, Sampath ^a   Martins, Thomas B ^b   Tebo, Anne E ^a,b   Whiting, April ^a   Clifford, Bronte ^a   Zeft, Andrew S ^a   McNally, Bernadette ^a   Bohnsack, John F ^a   Hill, Harry R ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SOLUBLE CD40 LIGAND; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; CHILD HEALTH; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD;

EID: 45849088380     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/1546-0096-6-8     Document Type: Article

References (39)

1. Woo P The cytokine network in juvenile chronic arthritis Rheum Dis Clin North Am 1997, 23(3):491-498 9287374 10.1016/S0889-857X(05)70344-6
2. Madson KL Moore TL Lawrence JM 3rd Osborn TG Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis J Rheumatol 1994, 21(12):2359-2363 7699643
3. Ozen S Saatci U Bakkaloglu A Ozdemir O Besbas N Kirazli S Ozdemir S Interleukin-1, -6, and -8 levels in juvenile chronic arthritis Clin Rheumatol 1997, 16(2):173-178 9093800 10.1007/BF02247847
4. Yilmaz M Kendirli SG Altintas D Bingol G Antmen B Cytokine levels in serum of patients with juvenile rheumatoid arthritis Clin Rheumatol 2001, 20(1):30-35 11254238 10.1007/s100670170100
5. Lotito AP Campa A Silva CA Kiss MH Mello SB Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis J Rheumatol 2007, 34(4):823-830 17343316
6. Shahin AA Shaker OG Kamal N Hafez HA Gaber W Shahin HA Circulating interleukin-6, soluble interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-10 levels in juvenile chronic arthritis: correlations with soft tissue vascularity assessed by power Doppler sonography Rheumatol Int 2002, 22(2):84-88 12070682 10.1007/ s00296-002-0191-1
7. De Benedetti F Robbioni P Massa M Viola S Albani S Martini A Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis Clin Exp Rheumatol 1992, 10(5):493-498 1458703
8. Mangge H Kenzian H Gallistl S Neuwirth G Liebmann P Kaulfersch W Beaufort F Muntean W Schauenstein K Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes Arthritis Rheum 1995, 38(2):211-220 7848311 10.1002/art.1780380209
9. Silverman ED Laxer RM Nelson DL Rubin LA Soluble interleukin-2 receptor in juvenile rheumatoid arthritis J Rheumatol 1991, 18(9):1398-1402 1757944
10. Grewal IS Flavell RA CD40 and CD154 in cell-mediated immunity Annual review of immunology 1998, 16:111-135 9597126 10.1146/ annurev.immunol.16.1.111
11. Grewal IS Flavell RA A central role of CD40 ligand in the regulation of CD4+ T-cell responses Immunology today 1996, 17(9):410-414 8854557 10.1016/0167-5699(96)10030-X
12. Banchereau J Bazan F Blanchard D Briere F Galizzi JP van Kooten C Liu YJ Rousset F Saeland S The CD40 antigen and its ligand Annual review of immunology 1994, 12:881-922 7516669 10.1146/annurev.iy.12.040194.004313
13. Spriggs MK Fanslow WC Armitage RJ Belmont J The biology of the human ligand for CD40 Journal of clinical immunology 1993, 13(6):373-380 7507124 10.1007/BF00920012
14. Dechanet J Grosset C Taupin JL Merville P Banchereau J Ripoche J Moreau JF CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells J Immunol 1997, 159(11):5640-5647 9548507
15. Koshy M Berger D Crow MK Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes J Clin Invest 1996, 98(3):826-837 8698875 10.1172/JCI118855 507493
16. Liu MF Chao SC Wang CR Lei HY Expression of CD40 and CD40 ligand among cell populations within rheumatoid synovial compartment Autoimmunity 2001, 34(2):107-113 11905840
17. Pietravalle F Lecoanet-Henchoz S Blasey H Aubry JP Elson G Edgerton MD Bonnefoy JY Gauchat JF Human native soluble CD40L is a biologically active trimer, processed inside microsomes J Biol Chem 1996, 271(11):5965-5967 8626375 10.1074/jbc.271.11.5965
18. Vakkalanka RK Woo C Kirou KA Koshy M Berger D Crow MK Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera Arthritis Rheum 1999, 42(5):871-881 10323442 10.1002/ 1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J
19. Tamura N Kobayashi S Kato K Bando H Haruta K Oyanagi M Kuriyama M Kipps TJ Hashimoto H Soluble CD154 in rheumatoid arthritis: Elevated plasma levels in cases with vasculitis J Rheumatol 2001, 28(12):2583-2590 11764201
20. Ludwiczek O Kaser A Tilg H Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases International journal of colorectal disease 2003, 18(2):142-147 12548417
21. Allanore Y Borderie D Meune C Lemarechal H Weber S Ekindjian OG Kahan A Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers Ann Rheum Dis 2005, 64(3):481-483 15708899 10.1136/ ard.2003.020040 1755392
22. Komura K Sato S Hasegawa M Fujimoto M Takehara K Elevated circulating CD40L concentrations in patients with systemic sclerosis J Rheumatol 2004, 31(3):514-519 14994397
23. Goules A Tzioufas AG Manousakis MN Kirou KA Crow MK Routsias JG Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases Journal of autoimmunity 2006, 26(3):165-171 16621447 10.1016/j.jaut.2006.02.002
24. Petty RE Southwood TR Manners P Baum J Glass DN Goldenberg J He X Maldonado-Cocco J Orozco-Alcala J Prieur AM Suarez-Almazor ME Woo P International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001 J Rheumatol 2004, 31(2):390-392 14760812
25. Fulton RJ McDade RL Smith PL Kienker LJ Kettman JR Jr. Advanced multiplexed analysis with the FlowMetrix system Clinical chemistry 1997, 43(9):1749-1756 9299971
26. Martins TB Pasi BM Pickering JW Jaskowski TD Litwin CM Hill HR Determination of cytokine responses using a multiplexed fluorescent microsphere immunoassay American journal of clinical pathology 2002, 118(3):346-353 12219776 10.1309/N0T6-C56B-GXB2-NVFB
27. Martins TB Pasi BM Litwin CM Hill HR Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum Clin Diagn Lab Immunol 2004, 11(2):325-329 15013983 10.1128/CDLI.11.2.325-329.2004 371198
28. Staros JV Wright RW Swingle DM Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions Analytical biochemistry 1986, 156(1):220-222 3740412 10.1016/0003-2697(86)90176-4
29. MacDonald KP Nishioka Y Lipsky PE Thomas R Functional CD40 ligand is expressed by T cells in rheumatoid arthritis J Clin Invest 1997, 100(9):2404-2414 9410920 10.1172/JCI119781 508439
30. Sekine C Yagita H Miyasaka N Okumura K Expression and function of CD40 in rheumatoid arthritis synovium J Rheumatol 1998, 25(6):1048-1053 9632061
31. Durie FH Fava RA Foy TM Aruffo A Ledbetter JA Noelle RJ Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40 Science 1993, 261(5126):1328-1330 7689748 10.1126/science.7689748
32. Wynne-Roberts CR Anderson CH Turano AM Baron M Light- and electron-microscopic findings of juvenile rheumatoid arthritis synovium: comparison with normal juvenile synovium Semin Arthritis Rheum 1978, 7(4):287-302 644340 10.1016/0049-0172(78)90027-6
33. de Jager W Hoppenreijs EP Wulffraat NM Wedderburn LR Kuis W Prakken BJ Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: A cross-sectional study Ann Rheum Dis 2007, 66(5):589-598 17170049 10.1136/ard.2006.061853
34. Lepore L Pennesi M Saletta S Perticarari S Presani G Prodan M Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis Clin Exp Rheumatol 1994, 12(5):561-565 7531125
35. De Benedetti F Pignatti P Bernasconi S Gerloni V Matsushima K Caporali R Montecucco CM Sozzani S Fantini F Martini A Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes J Rheumatol 1999, 26(2):425-431 9972980
36. Muller K Pedersen FK Wiik A Bendtzen K Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis. Clinical and laboratory correlations Rheumatol Int 1992, 12(3):89-92 1411093 10.1007/ BF00290260
37. Martins TB Anderson JL Muhlestein JB Horne BD Carlquist JF Roberts WL Carlquist JF Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay American journal of clinical pathology 2006, 125(6):906-913 16690490 10.1309/Q3E6KF0QD3U3YL6T
38. Martins TB Augustine NH Hill HR Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to group A streptococci Journal of immunological methods 2006, 316(1-2):97-106 17010371 10.1016/j.jim.2006.08.007
39. Sidiropoulos PI Boumpas DT Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients Lupus 2004, 13(5):391-397 15230298 10.1191/0961203304lu1032oa